Israel Englander Catalent, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Catalent, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,079,964 shares of CTLT stock, worth $245 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

4,079,964

Previous 1,820,180 124.15%

Holding current value

$245 Million

Previous $103 Million 123.28%

% of portfolio

0.11%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $121 Million - $129 Million	2,259,784 Added 124.15%	4,079,964 $229 Million
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $76.1 Million - $107 Million	1,787,022 Added 5389.41%	1,820,180 $103 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $16.2 Million - $23.5 Million	-504,229 Reduced 93.83%	33,158 $1.49 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $48 Million - $101 Million	-1,506,441 Reduced 73.71%	537,387 $23.3 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $30.6 Million - $49.9 Million	672,627 Added 49.05%	2,043,828 $134 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $31 Million - $60.7 Million	749,648 Added 120.61%	1,371,201 $61.7 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $20.9 Million - $32.7 Million	289,331 Added 87.09%	621,553 $45 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $3.58 Million - $4.68 Million	-41,024 Reduced 10.99%	332,222 $35.6 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $47.6 Million - $62.9 Million	-505,596 Reduced 57.53%	373,246 $41.4 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $15.6 Million - $18.1 Million	130,202 Added 17.39%	878,842 $113 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $25.2 Million - $32.9 Million	-230,970 Reduced 23.58%	748,640 $99.6 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $5.09 Million - $5.87 Million	-50,755 Reduced 4.93%	979,610 $106 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $21 Million - $25.9 Million	206,413 Added 25.05%	1,030,365 $109 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $3.58 Million - $4.39 Million	41,684 Added 5.33%	823,952 $85.7 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $23.7 Million - $30.1 Million	-325,669 Reduced 29.39%	782,268 $67 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $34.7 Million - $57.1 Million	722,983 Added 187.81%	1,107,937 $81.2 Million
Q1 2020 May 14, 2020	SELL	$36.95 - $62.95 $6.09 Million - $10.4 Million	-164,694 Reduced 29.96%	384,954 $20 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $21.3 Million - $25.6 Million	452,678 Added 466.82%	549,648 $30.9 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $1.89 Million - $2.31 Million	39,819 Added 69.67%	96,970 $4.62 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $610,021 - $842,314	-15,538 Reduced 21.38%	57,151 $3.1 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $10.3 Million - $15.2 Million	-345,196 Reduced 82.61%	72,689 $2.95 Million
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $149,600 - $231,468	4,995 Added 1.21%	417,885 $13 Million
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $31.6 Million - $35.9 Million	-787,377 Reduced 65.6%	412,890 $18.8 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $45.4 Million - $49.9 Million	1,172,638 Added 4244.23%	1,200,267 $50.3 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $20.3 Million - $24.4 Million	-515,441 Reduced 94.91%	27,629 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $53.6 Million - $61.9 Million	-1,438,903 Reduced 72.6%	543,070 $22.3 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $66.9 Million - $82.6 Million	1,981,973	1,981,973 $79.1 Million

Others Institutions Holding CTLT

# of Institutions

488

Shares Held

161M

Call Options Held

364K

Put Options Held

837K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.8B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account